Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2026)

Mereo BioPharma (MREO) has 4 years of Interest Coverage Ratio data on file, last reported at 438.3 in Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 438.3, down 604.28% year-over-year; the trailing twelve-month figure through Mar 2026 was 396.53 (down 5237.47% YoY), and the FY2025 annual result was 157.28, down 2083.58% from the prior year.
• Interest Coverage Ratio slipped to 438.3 in Q1 2026 per MREO's latest filing, from 364.78 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 114.54 in Q4 2024 and troughed at 438.3 in Q1 2026.
• A 4-year average of 130.1 and a median of 31.94 in 2024 frame the typical range for Interest Coverage Ratio.
• On a YoY basis, Interest Coverage Ratio climbed as much as 667.23% in 2024 and fell as far as 4811.92% in 2024.
• A 4-year view of Interest Coverage Ratio shows it stood at 20.19 in 2023, then soared by 667.23% to 114.54 in 2024, then tumbled by 418.48% to 364.78 in 2025, then declined by 20.15% to 438.3 in 2026.
• Business Quant data shows MREO's Interest Coverage Ratio at 438.3 in Q1 2026, 364.78 in Q4 2025, and 357.68 in Q3 2025.